tirzepatide glp 1 and gip Understand GLP-1/GIP Dual Agonist Its Effect on Current Weight Loss Therapy SeshDx | Root-Cause Women's Telehealth

ZP CON CBS 08NOV2023 Zepbound and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates

Clinicians should evaluate baseline renal function and reassess periodically, as metformin requires dose adjustment if eGFR declines below certain thresholds

[3] Clinical trials of tirzepatide, including the SURPASS and SURMOUNT programs involving over 10,000 participants, have not demonstrated a signal for increased incidence of thyroid cancer or thyroid nodules compared to placebo or active comparators during treatment periods up to two years

The maintenance guide addresses this challenge head-on, covering strategies for sustaining your results without the medication

doi:10.1007/s40264-023-01392-3 125